BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/24/2022 9:00:24 AM | Browse: 928 | Download: 2216
Publication Name World Journal of Clinical Cases
Manuscript ID 70587
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Case Report
Article Title Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report
Manuscript Source Unsolicited Manuscript
All Author List Ying Kong, Xiao-Cheng Xu and Liang Hong
ORCID
Author(s) ORCID Number
Ying Kong http://orcid.org/0000-0001-5153-3235
Xiao-Cheng Xu http://orcid.org/0000-0001-6268-1225
Liang Hong http://orcid.org/0000-0002-7327-0322
Funding Agency and Grant Number
Corresponding Author Liang Hong, MD, PhD, Associate Chief Physician, Department of Oncology, The First People’s Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, No. 199 Shixin South Road, Xiaoshan District, Hangzhou 311200, Zhejiang Province, China. kongying1504@163.com
Key Words Cerebral infarction; Pulmonary embolism; Bevacizumab; Chemotherapy; Non-small cell lung cancer; Case report
Core Tip This report describes a middle-aged man with postoperative recurrence of non-small cell lung cancer who developed cerebral infarction and pulmonary embolism 6 mo after treatment with bevacizumab, which was given in combination with chemotherapy. Concurrent arteriovenous thrombosis is rarely reported in the literature. Bevacizumab in conjunction with chemotherapy may increase the risk of arteriovenous thromboembolism. As a result, patients who undergo treatment with angiogenesis inhibitors should be carefully selected, and close monitoring and timely interventions (such as low-molecular-weight heparin prophylactic anticoagulant therapy) are necessary in order to reduce the risk of arterial thromboembolism and venous thromboembolism.
Publish Date 2022-06-24 09:00
Citation Kong Y, Xu XC, Hong L. Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report. World J Clin Cases 2022; 10(19): 6507-6513
URL https://www.wjgnet.com/2307-8960/full/v10/i19/6507.htm
DOI https://dx.doi.org/10.12998/wjcc.v10.i19.6507
Full Article (PDF) WJCC-10-6507.pdf
Full Article (Word) WJCC-10-6507.docx